北京时间2024年11月1日盘前,奥洛兹美医疗(HALO,LENZ)股价大涨16.67%,收于58.01美元,引发市场广泛关注。
公司此前公布的2024财年第三季度业绩显示,每股收益达到1.27美元,远超分析师预期的0.98美元。受业绩向好拉动,奥洛兹美还上调了全年收入预期,将原先的9.35亿到10.2亿美元上修至9.7亿至10.2亿美元。
公司预计,2024年全年特许权使用费收入将同比增长23%至26%,达到5.5亿至5.65亿美元;产品销售额也有较大增长。因此公司进一步上调每股收益预期,由之前的3.65至4.05美元上修至4.00至4.20美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.